WINTHROP’S SRIHARI S. NAIDU, MD, EARNS TWO PRESTIGIOUS APPOINTMENTS
Winthrop-University Hospital’s Srihari S. Naidu, MD, FACC, FAHA, FSCAI, Director of the Hospital’s Cardiac Catheterization Laboratory, Interventional Cardiology Fellowship Program, and Hypertrophic Cardiomyopathy Treatment Center, has been named to the American College of Cardiology Foundation/American Heart Association’s guideline writing committee for stable ischemic heart disease. Dr. Naidu is just one of two interventional cardiologists who have been appointed to the committee, which consists of 14 members including surgeons, internists and general cardiologists from around the country.
“Guidelines such as these hold considerable importance as they assist healthcare providers in the clinical decision-making process and serve as a definitive resource for managing the disease,” said Dr. Naidu. “Arguably the most important guideline in all of cardiology is the one that focuses on the management of patients with stable ischemic heart disease because it affects the vast majority of the patients we see.”
The guidelines, which will provide recommendations for the diagnosis and management of the disease, will also address the ongoing debate as to when stents should be inserted in patients with ischemic symptoms such as angina (chest pain).
The guidelines,“2014 ACCF/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients with Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Developed in Collaboration With the American Association for Thoracic Surgery, the Preventive Cardiovascular Nurses Association, The Society for Cardiovascular Angiography and Interventions, and The Society of Thoracic Surgeons,” are expected to be published in 2014 in both Circulation and the Journal of the American College of Cardiology (JACC), flagship journals of the American Heart Association and the American College of Cardiology, respectively.
Dr. Naidu was also recently among ten new members to be elected to the Board of Trustees for the Corporation of Brown University. Trustees serve six year terms, but remain Trustee Emeriti and are perpetually involved in standing committees of the University. Trustees are charged with overarching governance of the University, including strategic planning for both the College and the Medical School.
Dr. Naidu completed both his undergraduate and medical degrees at Brown in 1997. He then trained in internal medicine at Cornell and in interventional cardiology and general cardiology at the University of Pennsylvania. He joined Winthrop-University Hospital in 2006 after two years on the faculty at Cornell, and is now an Associate Professor of Medicine at Stony Brook University School of Medicine. Dr. Naidu is among the few interventionalists trained and experienced in treating Hypertrophic Cardiomyopathy, a form of heart disease that is the most common cause of sudden cardiac death among athletes, and a common form of heart failure in adults, with the advanced Alcohol Septal Ablation (ASA) technique. The treatment is only offered at select hospitals nationwide and provides a less invasive alternative to open-heart surgery.
Designated a Center of Excellence by the national Hypertrophic Cardiomyopathy Association (HCMA), Winthrop’s Hypertrophic Cardiomyopathy Center now serves over 350 patients and families with the disease, offering comprehensive, expert care for HCM including genetic testing and leading-edge therapies for patients who qualify.
During his time at Brown University, Dr. Naidu served as treasurer of the Undergraduate Council of Students and chair of the Undergraduate Finance Board. He is now president of the Brown Medical Alumni Association Board of Directors and looks forward to serving as an alumni trustee. Dr. Naidu will be formally inducted at the Corporation’s next meeting in October. Dr. Naidu resides in Manhattan, NY.
For more information about cardiac care at Winthrop-University Hospital, call 1-866-WINTHROP
# # #